Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$16.89 - $24.64 $2.27 Million - $3.31 Million
-134,135 Reduced 99.13%
1,177 $21,000
Q1 2023

May 15, 2023

SELL
$15.9 - $24.72 $2.01 Million - $3.13 Million
-126,494 Reduced 48.32%
135,312 $3.26 Million
Q4 2022

Feb 14, 2023

SELL
$10.7 - $17.84 $6.3 Million - $10.5 Million
-588,766 Reduced 69.22%
261,806 $4.21 Million
Q3 2022

Nov 14, 2022

SELL
$12.84 - $24.13 $3.67 Million - $6.9 Million
-285,911 Reduced 25.16%
850,572 $11.3 Million
Q2 2022

Aug 09, 2022

BUY
$16.75 - $22.54 $3.3 Million - $4.44 Million
196,956 Added 20.96%
1,136,483 $24.4 Million
Q1 2022

May 13, 2022

SELL
$17.89 - $28.73 $809,468 - $1.3 Million
-45,247 Reduced 4.59%
939,527 $20.2 Million
Q4 2021

Feb 09, 2022

BUY
$26.1 - $45.21 $14.5 Million - $25.2 Million
556,858 Added 130.13%
984,774 $28 Million
Q3 2021

Nov 15, 2021

BUY
$24.46 - $38.41 $10.5 Million - $16.4 Million
427,916 New
427,916 $14.2 Million

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.86B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.